Results 271 to 280 of about 9,647,508 (315)

Glymphatic dysfunction as a potential driver of cerebral iron deposition in Parkinson's disease. [PDF]

Brain Commun
Chen K, Ji Y, Zhang L, Zhang R, Li J, Lu L, Tang Y, Hu X, Wang F, Fang X.   +9 more
europepmc   +1 more source

Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease

, 2019
Robert A. Hauser, Stuart Isaacson, Aaron Ellenbogen, Beth Safirstein, Daniel Truong, Steven F. Komjathy, Deena M. Kegler-Ebo, Ping Zhao, Charles Oh   +8 more
openalex   +1 more source

Mapping the global research landscape of mitophagy in Parkinson's disease: a bibliometric and visualization analysis. [PDF]

Hereditas
Zhao J, Wang Q, Cao Y, Shan H, Xu S.
europepmc   +1 more source

Biochemical premotor biomarkers for Parkinson's disease

, 2012
Brit Mollenhauer, Jing Zhang
openalex   +2 more sources

Determining Medication Adherence in Patients Treated for Parkinson's Disease and Related Factors. [PDF]

Parkinsons Dis
Besharatpour M, Kavousi A, Salari M, Etemad K.   +3 more
europepmc   +1 more source

An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele

, 2019
Marian Shahid, Jeehyun Kim, Katherine Leaver, Taylor R. Hendershott, Delphine Zhu, Brenna Cholerton, Victor W. Henderson, Lü Tian, Kathleen L. Poston   +8 more
openalex   +2 more sources

Occurrence of Motor Complications and Gait Problems After Introduction of Medical Treatment in Parkinson's Disease. [PDF]

Parkinsons Dis
Osaki Y, Morita Y, Ohtsuru S, Shogase T, Yoshimoto D, Miyoshi T, Ikeda T, Hashimoto Y, Matsushita T.   +8 more
europepmc   +1 more source

Medio-Lateral Balance Impairment Differentiates between Parkinson's Disease and Atypical Parkinsonism

, 2014
Jorik Nonnekes, Marjolein B. Aerts, Wilson F. Abdo, Bastiaan R. Bloem   +3 more
openalex   +2 more sources

Clearance Pathways for α-Synuclein in Parkinson's Disease. [PDF]

J Neurochem
Ho MS.
europepmc   +1 more source